These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 16386359)

  • 1. MS treatment: new perspectives.
    Comi G; Martino G
    Clin Neurol Neurosurg; 2006 Mar; 108(3):339-45. PubMed ID: 16386359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy in multiple sclerosis.
    Fernández O
    J Neurol Sci; 2007 Aug; 259(1-2):95-103. PubMed ID: 17507031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modern multiple sclerosis treatment - what is approved, what is on the horizon.
    Pilz G; Wipfler P; Ladurner G; Kraus J
    Drug Discov Today; 2008 Dec; 13(23-24):1013-25. PubMed ID: 18775508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concepts of induction and escalation therapy in multiple sclerosis.
    Rieckmann P
    J Neurol Sci; 2009 Feb; 277 Suppl 1():S42-5. PubMed ID: 19200866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of worsening multiple sclerosis with mitoxantrone: a review.
    Fox EJ
    Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinically isolated syndromes: predicting and delaying multiple sclerosis.
    Thrower BW
    Neurology; 2007 Jun; 68(24 Suppl 4):S12-5. PubMed ID: 17562845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward the development of rational therapies in multiple sclerosis: what is on the horizon?
    Hemmer B; Hartung HP
    Ann Neurol; 2007 Oct; 62(4):314-26. PubMed ID: 17969020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinician's approach to modulate disease activity in MS.
    Cook SD
    Rev Neurol Dis; 2005; 2(3):117-23. PubMed ID: 16400310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowns and unknowns in the future of multiple sclerosis treatment.
    Stüve O
    J Neurol Sci; 2009 Dec; 287 Suppl 1():S30-6. PubMed ID: 20106346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shifting the paradigm toward earlier treatment of multiple sclerosis with interferon beta.
    Comi G
    Clin Ther; 2009 Jun; 31(6):1142-57. PubMed ID: 19695384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulatory drug treatment in multiple sclerosis.
    Aharoni R
    Expert Rev Neurother; 2010 Sep; 10(9):1423-36. PubMed ID: 20819013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future of multiple sclerosis treatment.
    Cohen JA
    J Neurol Sci; 2009 Feb; 277 Suppl 1():S55-61. PubMed ID: 19200869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trials of multiple sclerosis therapies: improvements to demonstrate long-term patient benefit.
    Carroll WM
    Mult Scler; 2009 Aug; 15(8):951-8. PubMed ID: 19465446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging therapies in multiple sclerosis.
    Farrell R; Heaney D; Giovannoni G
    Expert Opin Emerg Drugs; 2005 Nov; 10(4):797-816. PubMed ID: 16262563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New drug therapies for multiple sclerosis.
    Mangas A; Coveñas R; Geffard M
    Curr Opin Neurol; 2010 Jun; 23(3):287-92. PubMed ID: 20414110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daclizumab treatment for multiple sclerosis.
    Kim SE
    Pharmacotherapy; 2009 Feb; 29(2):227-35. PubMed ID: 19170591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addressing the need for increased adherence to multiple sclerosis therapy: can delivery technology enhance patient motivation?
    Lugaresi A
    Expert Opin Drug Deliv; 2009 Sep; 6(9):995-1002. PubMed ID: 19637982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy for the treatment of multiple sclerosis: challenges and opportunities.
    Stuart WH
    Curr Med Res Opin; 2007 Jun; 23(6):1199-208. PubMed ID: 17559719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting and preventing the future: actively managing multiple sclerosis.
    Hutchinson M
    Pract Neurol; 2009 Jun; 9(3):133-43, discussion 144. PubMed ID: 19448055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple sclerosis: interferon beta for some serious forms.
    Prescrire Int; 2007 Dec; 16(92):252-7. PubMed ID: 18092425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.